Vitamin D, Breast Cancer and Bone Health
Abstract
This is a multidisciplinary postdoctoral award investigating the role of vitamin D in aromatase inhibitor-induced osteoporosis in breast cancer, supporting studies in basic science, clinical research and epidemiology. During the reporting period, the recipient made significant progress in opening the clinical trial and progressing towards obtaining the MS degree in clinical epidemiology. The clinical trial received all necessary approvals including the IND from the FDA, and approvals from the IRB's from both at Stanford University and the DoD, and the trial is ongoing and recruiting participants. The recipient is scheduled to graduate in the Fall quarter 2009, and is currently working on the master's thesis on the role of vitamin D in breast cancer in general, with a special focus on aromatase inhibitor-induced bone loss. For the animal studies, the recipient obtained all necessary approvals for the experiments (Stanford University and DoD), and the studies will be performed during the third year.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 14, 2009
- Accession Number
- ADA518878
Entities
People
- Eva Balint
Organizations
- Stanford University